Mutualistic interplay between bacteriophages and bacteria in the human gut
Endocrinology and Diabetes, 15, 19
This confirms potency, sterility, and absence of contaminants
News provided by Ro Apr 09, 2026, 07:15 ET Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary NEW YORK, April 9, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Company's newest oral GLP-1 innovation on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s
However, there was a lack of comprehensive scientific studies to substantiate these claims, he noted